DFDA

Ceftriaxone

Treatment for Typhoid Fever

Typical Dosage: 1-2g IV/IM daily for 7-14 days

Effectiveness
93%
Safety Score
70%
Clinical Trials
2
Participants
4K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
1-2g IV/IM daily for 7-14 days
Time to Effect
3-5 days
Treatment Duration
7-14 days
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$1,000
Side Effect Mgmt:$50
Total Annual:$1,150
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$12,777/QALY
QALYs Gained
0.09
Outcome-Based Costs
Cost per Responder
$1,223
Cost per Remission
$1,277
Prescription Access Economics
Risk Assessment
Requires Monitoring
Yes
Needs lab work/checkups
Ceftriaxone Outcomes

for Typhoid Fever

Efficacy Outcomes
Overall Effectiveness
+93%
Response Rate
+94%
Remission Rate
+90%
Common Side Effects
Injection site pain
+8%
Diarrhea
+4%
Nausea
+2%
Rash
+1%

Sources:

cochrane.org
nih.gov
ox.ac.uk

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Ceftriaxone in Typhoid Fever

Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever

NCT01421693COMPLETEDPHASE4
View Study
300 participants
INTERVENTIONAL
Kathmandu, Nepal +1 more
Started: Sep 1, 2011